Open Orphan Share Discussion Threads

[malcolmmm] 24/11/2020 08:06

I would have thought that this appointment legitimises ORPH to those uncertain with someone of that stature on the board

[666james] 24/11/2020 07:58

Looks a good appointment. She also a NED for IP plc. This is what they are about:-

IP Group Plc is a private equity and venture capital firm specializing in seed, early stage, start-up, incubation, and mature financing. The firm also provides seed capital financing to spin out companies from the universities. It seeks to invest in the life sciences, physical sciences, energy & renewables, medical equipment and supplies, healthcare, technology, cleantech, intellectual property, pharmaceuticals & biotechnology, information technology & communications, and chemicals & materials. It also provides support for its university partners' intellectual property commercialization activities, as well as in the identification of intellectual property and in return takes equity positions in its portfolio companies. IP Group Plc was founded in 2001 and is based in London, United Kingdom with additional offices in Wilmington, Delaware; London, United Kingdom; Oxford, United Kingdom; and Melbourne, Australia.

[extrader] 24/11/2020 07:53

See also ex Longlad elsewehere,





.."The other finalists in the emerging category this year were: Darragh McCarthy of FinTru; Paddy Finn of Electricity Exchange; Joe Wiley of Amryt Pharma; Patrick J Rigney of the Shed Distillery; David and Sandra Whelan of VR Education; Eoin Leonard of i3PT Certification; and Noel O’Hanlon of Genesis Automation..."

And the (Irish) 'network effect'

.."“Already through this programme and the finalists we’ve started new collaborations and businesses, which might have happened anyhow but were accelerated because of the awards programme,” she added."

ATB

[extrader] 24/11/2020 07:40

Hi Lako42,

.."They must have many plans and irons in the fire that we aren't even aware of yet..."

Like : add top-notch businesswoman to the Board to Trader_3's 'long-list' of 'newsworthy' items.

All good stuff !

ATB

[molatovkid] 24/11/2020 07:40

Lako, I agree 100%. Either we are getting vast amounts of Irish blarney or there is something much larger being formed here.

I keep thinking I should be increasing my positions, while I can at these levels.

[judijudi] 24/11/2020 07:39

Happy with the appointment
Although when I clicked on the RNS I was hoping for a go ahead Challenge Study Confirmation RNS

[malcolmmm] 24/11/2020 07:39

Looks like a very good move by Cathal,
A very experienced internationally respected and capable person in the field ,nice one

[lako42] 24/11/2020 07:32

The potential here is bigger than any of us have previously thought imo.

They must have many plans and irons in the fire that we aren't even aware of yet.

Long long long

[lhoskins] 24/11/2020 07:28

Great RNS. The part I particularly like is"We look forward to working closely with Elaine who brings with her a wealth of knowledge and experience and will be invaluable addition to the Company as we now grow Open Orphan substantially in its next phase of rapid development."

[realcooltrader] 24/11/2020 07:14

Hmmm....”extensive start-up experience”

[owenski] 24/11/2020 07:13

Looks like a decent hiring.

"I look forward to working with them in the next stage of the evolution of Open Orphan."

[molatovkid] 24/11/2020 07:07

Like it - a high powered Board appointment. Should be able to open a few doors.

[rivaldo] 24/11/2020 07:06

Terrific new NED appointment - ex AZN, Lilly, on the board of IPO etc etc. Should bring in excellent contacts and hopefully new business.....

[malcolmmm] 23/11/2020 23:49

The Oxford Astra Zeneca vaccine will imo need challenge studies hence the government signing and paying a fee to ORPH. First of all its the most practical as it is cheap and lasts 6 months in an ordinary fridge whilst the other two need to be frozen and are much more expensive. Secondly it seems to prevent the most virulent forms of covid19,but the Oxford tests, using volunteers, was limited in number in comparison with the other two vaccines therefore leaving it open to noise (inaccuracies') in the results .
Oxford Astra Zeneca can apparently produce a billion doses at low prices in 2021 and can be afforded by third world countries and others including India with which they have apparently signed contracts to supply the vaccine and to highly populated countries such as Africa.
To save many hundreds of thousands of lives throughout the world a cheap and easily transported and stored vaccine is essential imo
For this to happen in the shortest possible time considering the limited vaccine testing by Oxford Astra Zeneca, surely challenge studies are essential, saving months of time lives and money.

[supernumerary] 23/11/2020 22:46

jj - they did need it but there wasn't one available so they just got on with it. Later arrivals will have better options.

[troutisout] 23/11/2020 21:52

Pennant formation still playing out nicely,


free stock charts from uk.advfn.com

[gregb] 23/11/2020 20:07

Not a silly question Judi. Listening to the last webinar will give you the answer.

[judijudi] 23/11/2020 19:51

Probably a very silly question
Why do companies need our CV challenge study facility when all the vaccines coming out haven’t used one 🤷‍a94;️ (to my knowledge)

[gregb] 23/11/2020 18:25

ORPH don't appear to be on the LSE webinar on 1st Dec. Oh well, not long to wait for the next one on the 9th. I thought CF was doing too many in any case.

[m5] 23/11/2020 17:18

Bit of a nothing day today TA wise. All as before. Price is squeezing into a pretty tight range now. We have a descending wedge forming, not a great lover of these, but it is when price becomes tight towards the end of the wedge and that can, not always, lead to a breakout in price. A little like a coiled spring if you will. If that does come into play, and as I say, not my favourite signal, you will be looking at Wednesday/Thursday as it gets to the end of the wedge. There will be people watching that area, for sure.

For me, as before,daily pin bar still in play from last Monday, that's the important one, and looking at the weekly chart it also shows rejection of the 22p area numerous times over the last month, so that is a very solid base IMHO. To confirm that, we have a large monthly pin bar forming aswell. Higher the time frame the better picture you get of price action and overall trend.

Potential Resistance is 26p, 28p and 32p.

Again guys, just my opinion for those interested. Nothing is nailed on as we all know, so as always DYOR and look after your money.

One point to add, do not use auto stops at the area I mentioned. You will get stop hunting going on. Hopefully we will not get there but just in case.

[malcolmmm] 23/11/2020 15:48

They certainly are thorough

[m5] 23/11/2020 13:14

1Day volunteer Chris Holdsworth speaks for @TheSun about the upcoming UK COVID-19 human challenge trial:

[trader_3] 23/11/2020 12:12

CHIMagents Covid CHIM in consultation with European Medicines Agency (EMA)

‘EMA is providing guidance to assist developers of potential COVID-19 medicines, to prepare for eventual applications for marketing authorisation.’

CHAG-COVID19-CA ChimAgents Challenge agent for human infection models Non-clinical phase



Good to see ORPH liaising with the EMA, in order to progress the Covid CHIM challenge agent in Europe.

Subsequent EMA authorisation will be a step change for ORPH and enable it to potentially utilise the Covid CHIM at the third facility (presumed 45 bedroom CHIM unit at SGS in Belgium).

IMHO

[lazarus2010] 23/11/2020 11:45

Qantas refusing to allow people to fly without a proof of vaccine so I heard